Improving Patient Outcomes
Not-for-profit research institute · Jackson Hole, Wyoming
- 81%
- of gifts go to research
- 50
- scientists in our consortium
- 20
- years in Jackson Hole
NoticeRead the notice
Deep fake videos impersonating us are not real.
Brain Chemistry Labs does not endorse, manufacture or sell “brain health” or any other supplements. If you see our scientists in a video promoting a product, it has been faked.
Section 01Why a nonprofit
Research that would not be viable in a pharmaceutical environment.
Unconstrained by pharmaceutical priorities, we can follow the evidence wherever it leads.
“It's hard not to see in Brain Chemistry Labs' grassroots international consortium a research model that's more flexible, responsive, curious, and humbly collaborative than the siloed, conservative approach of the pharmaceutical industry.”
| Brain Chemistry Labs | Pharma Inc. |
|---|---|
| Discovery focused | Commercially focused |
| Patient-centric | Profit-centric |
| Virtual and free-flowing | Bureaucratic hierarchy |
| Self-funded | Shareholders |
| Human chemistry | Inorganic chemistry |
| Efficient and fast | Slow and costly |
Section 02What your support has produced
Research highlights
“When I started looking into dementia and Alzheimer's, I didn't expect to be coming here. Nestled in these majestic Wyoming mountains is Dr. Paul Cox and his small non-profit, Brain Chemistry Labs.”
- 01ALS TestCurrently, many ALS patients have to wait for a year or more to receive an accurate diagnosis. Our new ALS Test has been validated as a CLIA/CAP laboratory-developed test.

- 02L-serine in FDA-approved Phase II trialsOur randomized, placebo-controlled trial of L-serine for Mild Cognitive Impairment at Houston Methodist will report in 2027. A repeat of our halted ALS trial, funded by a lead gift from Jackson Hole, Wyoming, will commence TBD, pending FDA approval.

- 03Beached dolphins have Alzheimer'sDolphins in coastal waters are sentinels for cyanobacterial toxins like the Lyngbya pictured. Our discovery of Alzheimer's neuropathology in their brains made the cover of Nature Communications Biology on September 30, 2025.

- 04A new drug candidate for Parkinson'sWe have identified a natural compound that stops the misfolding of alpha-synuclein, the protein behind Parkinson's, Lewy Body Disease and Multiple System Atrophy.

- 05Violets against glioblastomaSmall circular proteins from violets kill glioblastoma cells taken from living patients. With colleagues at the Medical University of Vienna we are moving as quickly as possible toward a Phase I trial for this lethal brain cancer.

- 06A rapid field test for the BMAA neurotoxinDetecting BMAA currently needs expensive laboratory equipment. We are developing an antibody-based kit, similar in principle to a pregnancy test, that water managers anywhere in the world could use.

Section 03For donors and their advisors
Due diligence, made easy.
Resource allocation · 2025 audit
- 81%
- of every gift goes to research
- 16%
- management and legal
- 3%
- fundraising
- Four-star rating from Charity Navigator
- A string of clean audits since the laboratory opened
- 501(c)(3) nonprofit · Tax ID 20-1829529
- Complete audit document available upon reasonable request
How you can help
Our scientists are constrained by research funding, not capacity.
As a not-for-profit organization, we care only for patients, not profits.
Our innovative approach is working, but we need your support. Based on our 2025 audit, 81% of all gifts go to medical research.
